DNAprint Genomics (DNAG)

[frogdreaming]

worktoplay,

I have a question for you regarding this line of speculation. It will be difficult for me to word in such a way as to not set of the regulars as negative spin, but I will attempt it anyway with the disclaimer that such is not my intention.

It is apparent that Gabriel and Tambori once held a fairly significant fraction of Biofrontera ownership. That share has recently dropped to a low level via the dilutive effects of new investments. Prior to that dilution Gabriel became associated with DNAP and the current strategy of drug pipeline acquisition was first broached.

The sequence of events that you have documented so carefully is much too focused to be coincidence and the plan seems to be one that has been in the works for years. Clearly Gabriel set out to bring DNAP and Biofrontera together from the start.

We, as a group, have been viewing the Biofrontera 'acquisition' from our own DNAP-centric viewpoint, but the driving force behind the association would seem to have originated with Gabriel before he connected up with DNAP. Would you agree?

Now here's the hard part of the question. Without raising the spectre of conflict of interest, does it not appear obvious to you that this deal reflects a larger picture in which some entity is financing the gathering together of a number of smaller companies into a larger conglomerate and is using DNAP as something of a front in that effort?

I can't escape the felling that DNAP is being carried along like a small boat adrift on a river. Seemingly moving in the right direction and moving quite fast, yet not necessarily in full control of the tiller and lacking any means to stop.

regards,
frog